Option chain shows key data for Heidelberg Materials's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Heidelberg Materials.

Heidelberg Materials (OTC:HDELY) Stock, Option Chain

HEIDELBERGCEMENT AG

HeidelbergCement

Heidelberg Materials is one of the world's largest building materials companies, with operations in 60 countries. Its core activities include the production of cement and aggregates, which are used to construct houses, infrastructure, and commercial facilities. The sale of cement and aggregates accounts for the majority of group revenue and profits. North America is the company's largest market, contributing 29% of EBITDA, followed by Western and Southern Europe, contributing 21%. Heidelberg Materials is listed in Germany and has 55,000 employees.

News

Intraday Update

Markets

Movers

Trading Ideas

AAEEF

AAVMY

ABEV

ABGSF

ABMD

ABTX

ACCFF

ACCYY

ACHV

ACNB

ACRFF

ACRGF

ACSAY

ACST

ACTG

ADMA

ADTN

ADVZF

AERI

AFLYY

AGCO

AGEEF

AGESY

AGLXY

AHFD

AHKSY

AHOTF

AICAF

AINV

AIPUY

AIRG

AIRYY

AISSF

AKO-A

AKZOY

ALDX

ALEAFIA HEALTH INC ORD by Aleafia Health Inc.

ALEAF

ALEX

Allianz Ag Muenchen Namen-Akt Vinkuliert Shares

ALIZF

ALLY

ALOT

ALSN

ALTM

ALXEF

ALXN

AMCR

AMHPF

AMKBF

AMKBY

AMNB

AMPH

AMRN

AMSLF

ANAT

ANGO

ANIP

Australia and New Zealand Banking Group Limited

ANZBY

ANZFF

APELY

APEX

APHA

APTS

ARCB

ARCC

ARGGY

ARGO

ARLP

ARNA

ARNGF

AROC

ARREF

ARRRF

Stocks That Hit 52-Week Lows On Friday

ABIO

ABVC

ACIW

ACOR

ACRX

ADHC

ADMP

AEGOF

AFRAF

AIBGY

AKRX

ALMFF

AMADY

AMCX

AMNP

AMRH

AMRQQ

AMTX

ANCN

ANZLY

APLE

AQARF

ARCH

ARTL

ASNA

ASTVF

ATRA

ATRI

ATROB

ATSG

ATUSF

AUTL

Stocks That Hit 52-Week Lows On Thursday

ABCE

AMGDF

APRN

ASIX

ATRO

AYTU

BCDRF

BFCH

BICEY

BNPUF

BOIVF

BORR

CDEV

CDZI

CESTY

CHRW

CJPRY

CJREF

CLVLF

CNDT

COWI

CPMD

CRWG

CSOD

China Shenhua Energy Unsponsored representing A shares

CSUAY

CTHR

CULP

CUYTF

CWSFF

CWVWF

CXXIF

DGRLY

DIFTY

DIIBF

DLTH

DMRC

DNTUY

DSSI

DXBRF

EJPRY

EKTAF

EKTAY

AB Electrolux Class B American Depositary Receipts

ELUXY

ELVT

ENLC

EZPW

FANG

FARE

FLMN

FLOOF

FLWPF

GGTTF

GLYE

GOGL

GPDNF

Stocks That Hit 52-Week Lows On Tuesday

HEIDELBERG MTRLS UNSP/ADR by HEIDELBERG MATERIALS AG

Heidelberg Materials AG

&nbsp;
<h2>Upgrades</h2>
<ul>
<li>For Methanex Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEOH#NASDAQ">MEOH</a>), Scotiabank upgraded the previous rating of Sector Perform to Sector Outperform. For the second quarter, Methanex had an EPS of $1.24, compared to year-ago quarter EPS of $0.84. The stock has a 52-week-high of $49.27 and a 52-week-low of $21.73. At the end of the last trading period, Methanex closed at $42.98.</li>
<li>For Teradata Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDC#NYSE">TDC</a>), Morgan Stanley upgraded the previous rating of Equal-Weight to Overweight. Teradata earned $0.74 in the second quarter, compared to $0.24 in the year-ago quarter. The stock has a 52-week-high of $59.58 and a 52-week-low of $17.99. At the end of the last trading period, Teradata closed at $50.61.</li>
<li>Credit Suisse upgraded the previous rating for Acadia Healthcare Co Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACHC#NASDAQ">ACHC</a>) from Neutral to Outperform. For the second quarter, Acadia Healthcare Co had an EPS of $0.71, compared to year-ago quarter EPS of $0.54. The current stock performance of Acadia Healthcare Co shows a 52-week-high of $68.65 and a 52-week-low of $27.07. Moreover, at the end of the last trading period, the closing price was at $61.22.</li>
<li>According to Deutsche Bank, the prior rating for Colgate-Palmolive Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CL#NYSE">CL</a>) was changed from Hold to Buy. In the second quarter, Colgate-Palmolive showed an EPS of $0.80, compared to $0.74 from the year-ago quarter. At the moment, the stock has a 52-week-high of $86.41 and a 52-week-low of $74.14. Colgate-Palmolive closed at $76.23 at the end of the last trading period.</li>
<li>Piper Sandler upgraded the previous rating for Ruth&#39;s Hospitality Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUTH#NASDAQ">RUTH</a>) from Neutral to Overweight. For the second quarter, Ruth&#39;s Hospitality Group had an EPS of $0.36, compared to year-ago quarter EPS of $0.48. The stock has a 52-week-high of $28.73 and a 52-week-low of $9.95. At the end of the last trading period, Ruth&#39;s Hospitality Group closed at $20.23.</li>
<li>For The One Group Hospitality Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STKS#NASDAQ">STKS</a>), Piper Sandler upgraded the previous rating of Neutral to Overweight. For the second quarter, The One Group Hospitality had an EPS of $0.19, compared to year-ago quarter EPS of $0.08. The current stock performance of The One Group Hospitality shows a 52-week-high of $13.34 and a 52-week-low of $1.85. Moreover, at the end of the last trading period, the closing price was at $10.37.</li>
<li>According to Jefferies, the prior rating for Visteon Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VC#NASDAQ">VC</a>) was changed from Hold to Buy. For the second quarter, Visteon had an EPS of $0.32, compared to year-ago quarter EPS of $1.44. The stock has a 52-week-high of $147.55 and a 52-week-low of $64.22. At the end of the last trading period, Visteon closed at $95.46.</li>
</ul>
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings upgrades.</a>
&nbsp;
<h2>Downgrades</h2>
<ul>
<li>For Novartis AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVS#NYSE">NVS</a>), Deutsche Bank downgraded the previous rating of Hold to Sell. For the second quarter, Novartis had an EPS of $1.66, compared to year-ago quarter EPS of $1.36. At the moment, the stock has a 52-week-high of $98.52 and a 52-week-low of $77.04. Novartis closed at $83.48 at the end of the last trading period.</li>
<li>Longbow Research downgraded the previous rating for Texas Instruments Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>) from Buy to Neutral. In the second quarter, Texas Instruments showed an EPS of $2.05, compared to $1.48 from the year-ago quarter. At the moment, the stock has a 52-week-high of $197.59 and a 52-week-low of $134.12. Texas Instruments closed at $196.25 at the end of the last trading period.</li>
<li>According to BMO Capital, the prior rating for Canadian National Railway Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNI#NYSE">CNI</a>) was changed from Outperform to Market Perform. Canadian National Railway earned $1.21 in the second quarter, compared to $0.92 in the year-ago quarter. The stock has a 52-week-high of $128.41 and a 52-week-low of $98.69. At the end of the last trading period, Canadian National Railway closed at $118.31.</li>
<li>According to SVB Leerink, the prior rating for Itamar Medical Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITMR#NASDAQ">ITMR</a>) was changed from Outperform to Market Perform. Itamar Medical earned $0.20 in the second quarter, compared to $0.17 in the year-ago quarter. At the moment, the stock has a 52-week-high of $30.46 and a 52-week-low of $16.36. Itamar Medical closed at $30.30 at the end of the last trading period.</li>
<li>Morgan Stanley downgraded the previous rating for Hill-Rom Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HRC#NYSE">HRC</a>) from Overweight to Equal-Weight. In the third quarter, Hill-Rom Holdings showed an EPS of $1.38, compared to $1.95 from the year-ago quarter. At the moment, the stock has a 52-week-high of $152.37 and a 52-week-low of $80.31. Hill-Rom Holdings closed at $150.50 at the end of the last trading period.</li>
<li>For Protagonist Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTGX#NASDAQ">PTGX</a>), JP Morgan downgraded the previous rating of Overweight to Neutral. In the second quarter, Protagonist Therapeutics showed an EPS of $0.69, compared to $0.59 from the year-ago quarter. At the moment, the stock has a 52-week-high of $50.54 and a 52-week-low of $15.51. Protagonist Therapeutics closed at $17.53 at the end of the last trading period.</li>
<li>For Lear Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEA#NYSE">LEA</a>), Jefferies downgraded the previous rating of Buy to Hold. In the second quarter, Lear showed an EPS of $2.45, compared to $4.14 from the year-ago quarter. The current stock performance of Lear shows a 52-week-high of $204.91 and a 52-week-low of $103.35. Moreover, at the end of the last trading period, the closing price was at $153.05.</li>
<li>According to Jefferies, the prior rating for BorgWarner Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWA#NYSE">BWA</a>) was changed from Buy to Hold. BorgWarner earned $1.08 in the second quarter, compared to $0.14 in the year-ago quarter. The stock has a 52-week-high of $55.55 and a 52-week-low of $34.30. At the end of the last trading period, BorgWarner closed at $42.92.</li>
</ul>
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings downgrades.</a>
&nbsp;
<h2>Initiations</h2>
<ul>
<li>Stifel initiated coverage on eFFECTOR Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EFTR#NASDAQ">EFTR</a>) with a Hold rating. The price target for eFFECTOR Therapeutics is set to $20.00. &nbsp;eFFECTOR Therapeutics closed at $19.30 at the end of the last trading period.</li>
<li>With a Buy rating, Craig-Hallum initiated coverage on Inotiv Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NOTV#NASDAQ">NOTV</a>). The price target seems to have been set at $45.00 for Inotiv. For the third quarter, Inotiv had an EPS of $0.15, compared to year-ago quarter EPS of $0.08. The stock has a 52-week-high of $35.98 and a 52-week-low of $17.22. At the end of the last trading period, Inotiv closed at $35.09.</li>
<li>With a Buy rating, B of A Securities initiated coverage on PAE Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAE#NASDAQ">PAE</a>). The price target seems to have been set at $8.00 for PAE. PAE earned $0.15 in the second quarter, compared to $0.17 in the year-ago quarter. The stock has a 52-week-high of $10.70 and a 52-week-low of $5.79. At the end of the last trading period, PAE closed at $5.90.</li>
<li>With an Outperform rating, Wedbush initiated coverage on Li-Cycle Holdings Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LICY#NYSE">LICY</a>). The price target seems to have been set at $14.00 for Li-Cycle Holdings. In the third quarter, Li-Cycle Holdings showed an EPS of $2.88, compared to $0.86 from the year-ago quarter. Moreover, at the end of the last trading period, the closing price was at $8.80.</li>
<li>Wells Fargo initiated coverage on Adobe Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>) with an Overweight rating. The price target for Adobe is set to $770.00. For the second quarter, Adobe had an EPS of $3.03, compared to year-ago quarter EPS of $2.45. The current stock performance of Adobe shows a 52-week-high of $673.88 and a 52-week-low of $420.78. Moreover, at the end of the last trading period, the closing price was at $654.48.</li>
<li>Wells Fargo initiated coverage on Salesforce.com Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) with an Overweight rating. The price target for Salesforce.com is set to $325.00. Salesforce.com earned $1.48 in the second quarter, compared to $1.44 in the year-ago quarter. The stock has a 52-week-high of $275.22 and a 52-week-low of $201.51. At the end of the last trading period, Salesforce.com closed at $260.53.</li>
<li>With an Overweight rating, Wells Fargo initiated coverage on Workday Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDAY#NASDAQ">WDAY</a>). The price target seems to have been set at $320.00 for Workday. For the second quarter, Workday had an EPS of $1.23, compared to year-ago quarter EPS of $0.84. The current stock performance of Workday shows a 52-week-high of $282.77 and a 52-week-low of $195.81. Moreover, at the end of the last trading period, the closing price was at $268.51.</li>
<li>With a Buy rating, Citigroup initiated coverage on Oatly Group AB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OTLY#NASDAQ">OTLY</a>). The price target seems to have been set at $21.00 for Oatly Group. Interestingly, in the second quarter, Oatly Group&#39;s EPS was $0.11. The current stock performance of Oatly Group shows a 52-week-high of $29.00 and a 52-week-low of $14.87. Moreover, at the end of the last trading period, the closing price was at $16.27.</li>
<li>RBC Capital initiated coverage on Ritchie Bros Auctioneers Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBA#NYSE">RBA</a>) with a Sector Perform rating. The price target for Ritchie Bros Auctioneers is set to $65.00. For the second quarter, Ritchie Bros Auctioneers had an EPS of $0.55, compared to year-ago quarter EPS of $0.54. The stock has a 52-week-high of $78.64 and a 52-week-low of $50.61. At the end of the last trading period, Ritchie Bros Auctioneers closed at $61.57.</li>
<li>HSBC initiated coverage on Ginkgo Bioworks Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DNA#NYSE">DNA</a>) with a Buy rating. The price target for Ginkgo Bioworks Holdings is set to $14.00. Ginkgo Bioworks Holdings closed at $12.18 at the end of the last trading period.</li>
<li>With a Equal-Weight rating, Barclays initiated coverage on Ardagh Metal Packaging SA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMBP#NYSE">AMBP</a>). The price target seems to have been set at $12.00 for Ardagh Metal Packaging. Ardagh Metal Packaging closed at $10.49 at the end of the last trading period.</li>
<li>With an Overweight rating, Keybanc initiated coverage on Global Medical REIT Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMRE#NYSE">GMRE</a>). The price target seems to have been set at $17.00 for Global Medical REIT. For the second quarter, Global Medical REIT had an EPS of $0.22, compared to year-ago quarter EPS of $0.19. The stock has a 52-week-high of $16.07 and a 52-week-low of $12.11. At the end of the last trading period, Global Medical REIT closed at $15.07.</li>
</ul>
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings initiations.</a>

Comments

Heidelberg Materials

Heidelberg Materials (HDELY) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga